The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus
Open accessAbstract
AIMS/HYPOTHESIS: Endothelial glycocalyx perturbation contributes to increased vascular permeability. In the present study we set out to evaluate whether: (1) glycocalyx is perturbed in individuals with type 2 diabetes mellitus, and (2) oral glycocalyx precursor treatment improves glycocalyx properties. METHODS: Male participants with type 2 diabetes (n = 10) and controls (n = 10) were evaluated before and after 2 months of sulodexide administration (200 mg/day). The glycocalyx dimension was estimated in two different vascular beds using sidestream dark field imaging and combined fluorescein/indocyanine green angiography for sublingual and retinal vessels, respectively. Transcapillary escape rate of albumin (TER(alb)) and hyaluronan catabolism were assessed as measures of vascular permeability. RESULTS: Both sublingual dimensions (0.64 [0.57-0.75] μm vs 0.78 [0.71-0.85] μm, p < 0.05, medians [interquartile range]) and retinal glycocalyx dimensions (5.38 [4.88-6.59] μm vs 8.89 [4.74-11.84] μm, p < 0.05) were reduced in the type 2 diabetes group compared with the controls whereas TER(alb) was increased (5.6 ± 2.3% vs 3.7 ± 1.7% in the controls, p < 0.05). In line with these findings, markers of hyaluronan catabolism were increased with diabetes (hyaluronan 137 ± 29 vs 81 ± 8 ng/ml and hyaluronidase 78 ± 4 vs 67 ± 2 U/ml, both p < 0.05). Sulodexide increased both the sublingual and retinal glycocalyx dimensions in participants with diabetes (to 0.93 [0.83-0.99] μm and to 5.88 [5.33-6.26] μm, respectively, p < 0.05). In line, a trend towards TER(alb) normalisation (to 4.0 ± 2.3%) and decreases in plasma hyaluronidase (to 72 ± 2 U/ml, p < 0.05) were observed in the diabetes group. CONCLUSION/INTERPRETATION: Type 2 diabetes is associated with glycocalyx perturbation and increased vascular permeability, which are partially restored following sulodexide administration. Further studies are warranted to determine whether long-term treatment with sulodexide has a beneficial effect on cardiovascular risk. TRIAL REGISTRATION: www.trialregister.nl NTR780/ http://isrctn.org ISRCTN82695186 FUNDING: An unrestricted Novartis Foundation for Cardiovascular Excellence grant (2006) to M. Nieuwdorp/E. S. G. Stroes, Dutch Heart Foundation (grant number 2005T037).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440
Signaling Mechanisms Regulating Endothelial Permeability
Mehta, D., & Malik, A. B. (2006) · Physiological Reviews · doi:10.1152/physrev.00012.2005 · Cited by 1,720
Albuminuria reflects widespread vascular damage: The Steno hypothesis
Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., & Kofoed-Enevoldsen, A. (1989) · Diabetologia · doi:10.1007/bf00285287 · Cited by 1,400
Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes
and the WHO Multinational Study Group, Morrish, N. J., Wang, S.-L., Stevens, L. K., Fuller, J. H., & Keen, H. (2001) · Diabetologia · doi:10.1007/pl00002934 · Cited by 1,288
Pries, A. R., Secomb, T. W., & Gaehtgens, P. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240000307 · Cited by 898
Nieuwdorp, M., van Haeften, T. W., Gouverneur, M. C. L. G., Mooij, H. L., van Lieshout, M. H. P., Levi, M., Meijers, J. C. M., Holleman, F., Hoekstra, J. B. L., Vink, H., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-1103 · Cited by 620
Self-citationVink, H., & Duling, B. R. (1996) · Circulation Research · doi:10.1161/01.res.79.3.581 · Cited by 615
Self-citationThe Endothelial Glycocalyx Protects Against Myocardial Edema
van den Berg, B. M., Vink, H., & Spaan, J. A. E. (2003) · Circulation Research · doi:10.1161/01.res.0000065917.53950.75 · Cited by 531
Self-citationHexosamines, insulin resistance, and the complications of diabetes: current status
Buse, M. G. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00329.2005 · Cited by 512
Endothelial Glycocalyx Damage Coincides With Microalbuminuria in Type 1 Diabetes
Nieuwdorp, M., Mooij, H. L., Kroon, J., Atasever, B., Spaan, J. A. E., Ince, C., Holleman, F., Diamant, M., Heine, R. J., Hoekstra, J. B. L., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1619 · Cited by 442
Self-citationPermeation of the luminal capillary glycocalyx is determined by hyaluronan
Henry, C. B. S., & Duling, B. R. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.2.h508 · Cited by 426
Endothelial Cell Glycocalyx Modulates Immobilization of Leukocytes at the Endothelial Surface
Constantinescu, A. A., Vink, H., & Spaan, J. A. E. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000085630.24353.3d · Cited by 379
Self-citationEndothelial cell heterogeneity
Aird, W. C. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000057847.32590.c1 · Cited by 324
Glomerular Endothelial Glycocalyx Constitutes a Barrier to Protein Permeability
Singh, A., Satchell, S. C., Neal, C. R., McKenzie, E. A., Tooke, J. E., & Mathieson, P. W. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010119 · Cited by 300
Rossetti, L., Hawkins, M., Chen, W., Gindi, J., & Barzilai, N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118013 · Cited by 264
Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury
Rubio-Gayosso, I., Platts, S. H., & Duling, B. R. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00796.2005 · Cited by 262
Impaired Tubular Uptake Explains Albuminuria in Early Diabetic Nephropathy
Russo, L. M., Sandoval, R. M., Campos, S. B., Molitoris, B. A., Comper, W. D., & Brown, D. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050503 · Cited by 261
Jeansson, M., & Haraldsson, B. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00173.2005 · Cited by 231
Chappell, D., Jacob, M., Paul, O., Rehm, M., Welsch, U., Stoeckelhuber, M., Conzen, P., & Becker, B. F. (2009) · Circulation Research · doi:10.1161/circresaha.108.187831 · Cited by 218
Nieuwdorp, M., Meuwese, M. C., Mooij, H. L., Ince, C., Broekhuizen, L. N., Kastelein, J. J. P., Stroes, E. S. G., & Vink, H. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00440.2007 · Cited by 210
Self-citationGambaro, G., Kinalska, I., Oksa, A., Pont’uch, P., Hertlová, M., Olsovsky, J., Manitius, J., Fedele, D., Czekalski, S., Perusicová, J., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000014254.87188.e5 · Cited by 192
Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion
Chappell, D., Jacob, M., Hofmann-Kiefer, K., Rehm, M., Welsch, U., Conzen, P., & Becker, B. F. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp097 · Cited by 188
The Recovery Time Course of the Endothelial Cell Glycocalyx In Vivo and Its Implications In Vitro
Potter, D. R., Jiang, J., & Damiano, E. R. (2009) · Circulation Research · doi:10.1161/circresaha.108.191585 · Cited by 176
Localization of the permeability barrier to solutes in isolated arteries by confocal microscopy
van Haaren, P. M. A., VanBavel, E., Vink, H., & Spaan, J. A. E. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00117.2003 · Cited by 161
Self-citationWang, A., & Hascall, V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312045200 · Cited by 111
Nieuwdorp, M., Holleman, F., de Groot, E., Vink, H., Gort, J., Kontush, A., Chapman, M. J., Hutten, B. A., Brouwer, C. B., Hoekstra, J. B. L., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0666-4 · Cited by 108
Self-citationHeparinase selectively sheds heparan sulphate from the endothelial glycocalyx
Chappell, D., Jacob, M., Rehm, M., Stoeckelhuber, M., WELSCH, U. N., Conzen, P. F., & Becker, B. F. (2007) · Biological Chemistry · doi:10.1515/bc.2008.005 · Cited by 95
Ceol, M., Gambaro, G., Sauer, U., Baggio, B., Anglani, F., Forino, M., Facchin, S., Bordin, L., Weigert, C., NERLICH, A., et al. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11122324 · Cited by 86
A Role for the Endothelial Glycocalyx in Regulating Microvascular Permeability in Diabetes Mellitus
Perrin, R. M., Harper, S. J., & Bates, D. O. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0041-6 · Cited by 78
Sulodexide suppresses inflammation in human endothelial cells and prevents glucose cytotoxicity
Ciszewicz, M., Połubińska, A., Antoniewicz, A. A., Sumińska-Jasińska, K., & Bręborowicz, A. (2009) · Translational research · doi:10.1016/j.trsl.2008.12.007 · Cited by 71
A randomized, controlled study of sulodexide therapy for the treatment of diabetic nephropathy
Dedov, I. I. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.11.2295 · Cited by 62
Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria
Heerspink, H. J. L., Greene, T., Lewis, J. B., et al. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm893 · Cited by 61
The Role of Sulodexide in the Treatment of Diabetic Nephropathy
Weiss, R., Niecestro, R., & Raz, I. (2007) · Drugs · doi:10.2165/00003495-200767180-00004 · Cited by 48
Nosadini, R., Velussi, M., Brocco, E., Abaterusso, C., Piarulli, F., Morgia, G., Satta, A. E., Faedda, R., Abhyankar, A., Luthman, H., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.1.228 · Cited by 36
Heerspink, H. J. L., Fowler, M. J., Volgi, J., Reutens, A. T., Klein, I., Herskovits, T., Packham, D., Fraser, I. R., Schwartz, S. L., Abaterusso, C., et al. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02249.x · Cited by 33
Microvascular permeability during experimental human endotoxemia: an open intervention study
van Eijk, L. T., Pickkers, P., Smits, P., van den Broek, W., Bouw, M. P. W. J. M., & van der Hoeven, J. G. (2005) · Critical Care · doi:10.1186/cc3050 · Cited by 33
Heparan Sulfate Analysis from Diabetic Rat Glomeruli
Lauer, M. E., Hascall, V., & Wang, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608823200 · Cited by 32
Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats.
Higashi, S., Clermont, A., Dhir, V., et al. (1998) · Diabetes · doi:10.2337/diabetes.47.4.653 · Cited by 31
Effect of danaparoid sodium on hard exudates in diabetic retinopathy
van der Pijl, J. W., van der Woude, F. J., Swart, W., van Es, L. A., & Lemkes, H. H. P. J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07126-2 · Cited by 29
Cited by
Xu, S., Ilyas, I., Little, P. J., Li, H., Kamato, D., Zheng, X., Luo, S., Li, Z., Liu, P., Han, J., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000096 · Cited by 1,142
Klaassen, I., Van Noorden, C. J. F., & Schlingemann, R. O. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.02.001 · Cited by 722
Self-citationVascular endothelium – Gatekeeper of vessel health
Cahill, P. A., & Redmond, E. M. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.007 · Cited by 518
The endothelial glycocalyx: a review of the vascular barrier
Alphonsus, C. S., & Rodseth, R. N. (2014) · Anaesthesia · doi:10.1111/anae.12661 · Cited by 460
Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases
Becker, B. F., Jacob, M., Leipert, S., Salmon, A. H. J., & Chappell, D. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12629 · Cited by 464
Metadata
- Authors
- Broekhuizen, L. N., Lemkes, B. A., Mooij, H. L., Meuwese, M. C., Verberne, H., Holleman, F., Schlingemann, R. O., Nieuwdorp, M., Stroes, E. S. G., & Vink, H.
- Venue
- Diabetologia
- Published
- 2010-09-25
- Volume
- 53
- Issue
- 12
- Pages
- 2646-2655
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1991448459
- Cited by
- 406
- References
- 40
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.